Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Hasbani and the UNICEF Launched the National Breastfeeding Campaign

The Ministry of Public Health launched the National Breastfeeding Campaign in collaboration with the UNICEF and the International Orthodox Christian Charities during a special event held at Linda Sursock Villa, Achrafieh under the title: “Breastfeeding is important; the mission of all of us! It is our duty to support you and your right to ask support”.

The event started with an opening statement delivered by the Head of the Mother, child and school health Department Pamela Zgheib who stated that the Lebanese Ministry of Public Health and the World health Organization recommend mothers to exclusively breastfeed their children for their first six months. Therefore, they should be given water and nutritious supplements and continue breastfeeding up to two years and beyond.

The Chairperson of the International Orthodox Christian Charities Rouba Khoueiry highlighted the importance of raising awareness on breastfeeding and encouraging both private and public sectors to provide mothers with facilities for breastfeeding.
 
ChapuisatTanya Chapuisat, UNICEF Lebanon Representative, said that the latest survey carried out in Lebanon shows that the exclusive breastfeeding rate for the child’s first six months is 14.8% for the Lebanese mothers. This means that a significant number of infants in this country are deprived of the most important elements for their growth and health. According to Chapuisat, extending the scope of breastfeeding can help save 823,000 children below 5 years yearly.
 
Hasbani

“Breastfeeding is not only good for mothers and infants, it is also important in achieving several sustainable development goals; enhancing nutrition, preventing children death, reducing NCD risks and promoting the cognitive development and learning. Breastfeeding helps also reduce poverty and inequality and enhance the economic growth,” Hasbani said.

“Breastfeeding improves as well the national economy, since it reduces the primary healthcare bill and improves the educational attainments, and therefore increases productivity,” he added.

Hasbani announced that the Ministry of Public Health commits itself to improve breastfeeding rate in Lebanon through a national plan to improve and protect breastfeeding.
 
Nadine Hasbani

As a mother for three children and a dietitian, Mrs. Nadine Ghassan Hasbani highlighted the importance of breastfeeding and its positive impact on the child’s growth, in addition to its role in strengthening his immunization system, and protecting him from chronic diseases. As for mothers, breastfeeding helps them burn fat and calories accumulated during pregnancy, and helps the uterus return to its normal size before pregnancy.
Mrs. Hasbani encouraged breastfeeding that enhances the relationship between the mother and the child.
    1
ATC Name B/G Ingredients Dosage Form Price
S01ED51 XALACOM B Timolol (maleate) - 6.8mg/ml, Latanoprost - 50?g/ml Drops solution 510,660 L.L
S01EE01 XALAPROST G Latanoprost - 0.005% w/v 0.005% w/v Drops solution 421,967 L.L
S01EE01 XALATAN B Latanoprost - 50mcg/ml 50mcg/ml Drops solution 704,173 L.L
N05AX12 XALIPRO G Aripiprazole - 10mg 10mg Tablet 2,123,271 L.L
N05AX12 XALIPRO G Aripiprazole - 15mg 15mg Tablet 2,418,917 L.L
N05AX12 XALIPRO G Aripiprazole - 5mg 5mg Tablet 1,746,995 L.L
L01ED01 XALKORI B Crizotinib - 250mg 250mg Capsule L.L
L01ED01 XALKORI B Crizotinib - 250mg 250mg Capsule 347,644,061 L.L
L01ED01 XALKORI B Crizotinib - 200mg 200mg Capsule 347,644,061 L.L
N05BA12 XANAX B Alprazolam - 0.5mg 0.5mg Tablet 477,064 L.L
B01AF01 XARELTO B Rivaroxaban - 2.5mg 2.5mg Tablet, film coated 4,045,168 L.L
B01AF01 XARELTO B Rivaroxaban - 15mg 15mg Tablet, film coated 4,440,862 L.L
B01AF01 XARELTO B Rivaroxaban - 20mg 20mg Tablet, film coated 4,440,862 L.L
B01AF01 XARELTO B Rivaroxaban - 10mg 10mg Tablet, film coated 1,588,892 L.L
G04CA01 XATRAL XL B Alfuzosin HCl - 10mg 10mg Tablet, prolonged release 1,061,636 L.L
B01AF01 XAVIRAN G Rivaroxaban - 15mg 15mg Tablet, film coated 952,208 L.L
B01AF01 XAVIRAN G Rivaroxaban - 20mg 20mg Tablet, film coated 952,208 L.L
B01AF01 XAVIRAN G Rivaroxaban - 10mg 10mg Tablet, film coated 606,649 L.L
L04AA29 XELJANZ B Tofacitinib - 5mg 5mg Tablet L.L
L04AA29 XELJANZ B Tofacitinib - 5mg 5mg Tablet 80,685,473 L.L
L04AA29 XELJANZ XR B Tofacitinib - 11mg 11mg Tablet, extended release 78,687,316 L.L
L01BC06 XELODA B Capecitabine - 500mg 500mg Tablet, film coated 17,946,398 L.L
D07AC13 XEMADERM G Mometasone furoate - 0.1% 0.1% Cream 335,961 L.L
A08AB01 XENICAL B Orlistat - 120mg 120mg Capsule 4,036,903 L.L
M03AX01 XEOMIN BioTech Clostridium botulinum type A neurotoxin complex - 100 units LD50 100 units LD50 Injectable powder for solution 20,517,541 L.L
M03AX01 XEOMIN BioTech Clostridium botulinum type A neurotoxin complex - 50 units LD50 50 units LD50 Injectable powder for solution 11,920,109 L.L
J01DD15 XEVANEER G Cefdinir - 300mg 300mg Capsule 1,350,562 L.L
J01DD15 XEVANEER G Cefdinir - 125mg/5ml 125mg/5ml Powder for suspension 1,308,903 L.L
J01DD15 XEVANEER G Cefdinir - 125mg/5ml 125mg/5ml Powder for suspension 686,704 L.L
M05BX04 XGEVA BioTech Denosumab - 120mg 120mg Injectable solution 33,545,669 L.L
    1
Sitemap
© Copyrights reserved to Ministry of Public Health 2026